The Effect of Alendronate in the Treatment of Osteopenia due to Acute Leukemia
Phase 2
Recruiting
- Conditions
- Condition 1: Acute Lymphoblastic Leukemia. Condition 2: Acute Myeloblastic Leukemia.Acute lymphoblastic leukemia [ALL]Acute myeloblastic leukemiaC91.0C92.0
- Registration Number
- IRCT20200916048733N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Children under 15 years
Children with acute lymphoblastic leukemia
Children with acute myeloblastic leukemia
Exclusion Criteria
Children with chronic leukemia
Children under 2 years
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method